title: A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer.
authors.affiliation: H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. eric.haura@moffitt.org
authors.forename: Eric B
authors.initials: EB
authors.lastname: Haura
authors.forename: Alejandro D
authors.initials: AD
authors.lastname: Ricart
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Larson
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Stella
authors.forename: Lyudmila
authors.initials: L
authors.lastname: Bazhenova
authors.forename: Vincent A
authors.initials: VA
authors.lastname: Miller
authors.forename: Roger B
authors.initials: RB
authors.lastname: Cohen
authors.forename: Peter D
authors.initials: PD
authors.lastname: Eisenberg
authors.forename: Paulina
authors.initials: P
authors.lastname: Selaru
authors.forename: Keith D
authors.initials: KD
authors.lastname: Wilner
authors.forename: Shirish M
authors.initials: SM
authors.lastname: Gadgeel